Recent studies have revealed that the down-regulation of ligands for NK cell activating receptors or some NK activating receptors and the activation of NK inhibitory receptors may promote AML cell evasion from NK recognition. The gene discussed is SLAMF6; the disease is acute myeloid leukemia.